BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16134447)

  • 21. Attention deficit hyperactivity disorder in preschool children.
    Greenhill LL; Posner K; Vaughan BS; Kratochvil CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):347-66, ix. PubMed ID: 18295150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosocial interventions in attention deficit hyperactivity disorder.
    Antshel KM; Barkley R
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):421-37, x. PubMed ID: 18295154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results.
    Wigal SB; Wilens TE; Wolraich M; Lerner M
    Pediatrics; 2007 Jul; 120(1):e120-8. PubMed ID: 17548486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The hyperactive child: diagnosis and therapy].
    Steinhausen HC
    Praxis (Bern 1994); 2001 May; 90(22):969-73. PubMed ID: 11450184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Malnutrition in children with DAMP?].
    Andersen LL
    Ugeskr Laeger; 2009 Mar; 171(10):824. PubMed ID: 19280776
    [No Abstract]   [Full Text] [Related]  

  • 26. Childhood attention-deficit/hyperactivity disorder.
    Verkuijl N; Perkins M; Fazel M
    BMJ; 2015 May; 350():h2168. PubMed ID: 25994532
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful child psychotherapy of attention deficit/hyperactive disorder: an agitated depression explanation.
    Seitler BN
    Am J Psychoanal; 2008 Sep; 68(3):276-94. PubMed ID: 18756317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When children with attention-deficit/hyperactivity disorder become adults.
    Stern HP; Stern TP
    South Med J; 2002 Sep; 95(9):985-91. PubMed ID: 12356139
    [No Abstract]   [Full Text] [Related]  

  • 29. The diagnosis and management of attention-deficit/hyperactivity disorder in preschool children: the state of our knowledge and practice.
    Dreyer BP
    Curr Probl Pediatr Adolesc Health Care; 2006 Jan; 36(1):6-30. PubMed ID: 16360075
    [No Abstract]   [Full Text] [Related]  

  • 30. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [After the researchers have left the field].
    Boer F
    Tijdschr Psychiatr; 2007; 49(8):525-7. PubMed ID: 17824135
    [No Abstract]   [Full Text] [Related]  

  • 32. [Management of attention deficit and hyperactivity disorder].
    Porter B; Bar-David Y; Galil A
    Harefuah; 1991 Aug; 121(3-4):94-7. PubMed ID: 1752583
    [No Abstract]   [Full Text] [Related]  

  • 33. Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic approaches.
    DelBello MP
    J Clin Psychiatry; 2008 Jan; 69(1):130. PubMed ID: 18312047
    [No Abstract]   [Full Text] [Related]  

  • 34. [Multimodal treatment concepts in children and adolescents with attention deficit/hyperactive disorder].
    Lehmkuhl G
    MMW Fortschr Med; 2005 Dec; 147(48):32-4, 36. PubMed ID: 16389859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attention-deficit/hyperactivity disorder.
    Joughin C; Ramchandani P; Zwi M
    Am Fam Physician; 2003 May; 67(9):1969-70. PubMed ID: 12751659
    [No Abstract]   [Full Text] [Related]  

  • 36. Attention deficit/hyperactivity disorder in adults.
    Moss SB; Nair R; Vallarino A; Wang S
    Prim Care; 2007 Sep; 34(3):445-73, v. PubMed ID: 17868755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medical treatments of hyperactive child: about the new pharmaceutical forms of methylphenidate marketed in France].
    Le Heuzey MF; Vergnaud S; Mouren MC
    Arch Pediatr; 2006 Jan; 13(1):100-3. PubMed ID: 16239100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug therapy in the treatment of minimal brain dysfunction.
    Saccar CL
    Am J Hosp Pharm; 1978 May; 35(5):544-52. PubMed ID: 26219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
    Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ
    Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.